0001209191-15-072320.txt : 20150928
0001209191-15-072320.hdr.sgml : 20150928
20150928171525
ACCESSION NUMBER: 0001209191-15-072320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150924
FILED AS OF DATE: 20150928
DATE AS OF CHANGE: 20150928
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 38 SIDNEY STREET
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-272-5275
MAIL ADDRESS:
STREET 1: 38 SIDNEY STREET
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goddard Glenn
CENTRAL INDEX KEY: 0001581992
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 151128181
MAIL ADDRESS:
STREET 1: C/O AGIOS PHARMACEUTICALS, INC.
STREET 2: 38 SIDNEY STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-24
0
0001439222
AGIOS PHARMACEUTICALS INC
AGIO
0001581992
Goddard Glenn
C/O AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Senior Vice President, Finance
Common stock
2015-09-24
4
M
0
10000
A
10000
D
Common stock
2015-09-24
4
F
0
4856
88.89
D
5144
D
Common stock
2015-09-24
4
M
0
856
23.10
A
6000
D
Common stock
2015-09-24
4
S
0
6000
85.97
D
0
D
Restricted stock units
2015-09-24
4
M
0
10000
0.00
D
Common stock
10000
0
D
Stock option (right to buy)
23.10
2015-09-24
4
M
0
856
0.00
D
2023-08-27
Common stock
856
88242
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $85.09 to $87.70. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
The restricted stock units were granted on September 24, 2014 and vested in full on September 24, 2015.
This option was granted on August 28, 2013. The shares underlying this option vest as to 25% of the underlying shares on August 28, 2014, with the remaining 75% vesting in 36 equal monthly installments thereafter.
/s/ Glenn Goddard
2015-09-28